ArticleCancer communications (London, England)2025

Semaglutide impairs bioavailability of alectinib: a note of warning based on a cross-over pharmacokinetic drug-drug interaction study.

Niels Heersche et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.